Prostate Cancer - Results from #20560

The 20th Annual Prostate Cancer Foundation Scientific Retreat report - Abstract May 15, 2014

Unrecognized kinetics of serum testosterone: Impact on short-term androgen deprivation therapy for prostate cancer - Abstract May 15, 2014

The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer - Abstract May 15, 2014

The effect of differing Gleason scores at biopsy on the odds of upgrading and the risk of death from prostate cancer - Abstract May 15, 2014

Radium-223 in metastatic castration resistant prostate cancer - Abstract May 15, 2014

The role of SPECT/CT in skeletal malignancies - Abstract May 15, 2014

NICE issues preliminary recommendations on earlier treatment with abiraterone for prostate cancer May 15, 2014

Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy - Abstract May 14, 2014

Circulating biomarkers for discriminating indolent from aggressive disease in prostate cancer active surveillance - Abstract May 14, 2014

Management of low risk prostate cancer: Active surveillance and focal therapy - Abstract May 14, 2014

Assessment of prostate cancer with dynamic contrast-enhanced computed tomography using an en bloc approach - Abstract May 14, 2014

Surface-constrained nonrigid registration for dose monitoring in prostate cancer radiotherapy - Abstract May 14, 2014

Multiparametric MRI and subsequent MR/ultrasound fusion-guided biopsy increase the detection of anteriorly located prostate cancers - Abstract May 14, 2014

Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer - Abstract May 14, 2014

Maximal testosterone suppression in prostate cancer-free vs total testosterone - Abstract May 14, 2014

Repackaging prostate cancer support group research findings: An e-KT case study - Abstract May 14, 2014

Metastatic castrate-resistant prostate cancer with a late, complete and durable response to docetaxel chemotherapy: A case report - Abstract May 14, 2014

Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: A feasibility study - Abstract May 12, 2014

The presence of a pituitary tumor in patients with prostate cancer is not a contraindication for leuprolide therapy - Abstract May 12, 2014

Changes in levels of prostate-specific antigen and testosterone following discontinuation of long-term hormone therapy for non-metastatic prostate cancer - Abstract May 12, 2014

Page 1029 of 1435